FTSE 100 movers: Spirax stands out; Convatec gives back some gains
London's FTSE 100 was up 0.5% at 8,069.27 in afternoon trade on Thursday.
Spirax was the standout gainer on the index as it left its full-year outlook unchanged after increasing organic sales across all three of its businesses in the third quarter, but warned of a slight impact on results from currency movements.
3i Group also pushed higher as it highlighted a "good" financial performance in the first half, with a total return of £2.05bn, or 10% on opening shareholders' funds.
B&M European Value Retail gained as it reiterated its full-year outlook after half-year sales ticked higher.
United Utilities rose as it said revenues topped the £1bn mark in its first half after a "robust" performance, though headline profits dropped due to a higher net finance expense.
Aviva advanced as it hailed a "very strong" performance in the third quarter, with double-digit gains in general insurance premiums, life insurance and retirement sales, and wealth net flows.
On the downside, Convatec was the worst performer on the index, having surged earlier in the week after raising its guidance for 2024 following robust sales growth across its divisions.
Sainsbury's lost ground as it traded without entitlement to the dividend.
FTSE 100 - Risers
Spirax Group (SPX) 6,680.00p 4.87%
3i Group (III) 3,480.00p 4.50%
B&M European Value Retail S.A. (DI) (BME) 396.70p 4.45%
United Utilities Group (UU.) 1,090.50p 4.01%
Aviva (AV.) 472.70p 3.96%
Informa (INF) 853.00p 3.14%
Severn Trent (SVT) 2,649.00p 2.52%
BP (BP.) 378.85p 2.38%
Prudential (PRU) 623.00p 2.23%
Centrica (CNA) 120.95p 2.07%
FTSE 100 - Fallers
Convatec Group (CTEC) 247.20p -3.59%
Fresnillo (FRES) 622.00p -1.82%
Weir Group (WEIR) 2,124.00p -1.76%
Experian (EXPN) 3,699.00p -1.75%
Sainsbury (J) (SBRY) 239.00p -1.73%
Intermediate Capital Group (ICG) 2,046.00p -1.54%
DCC (CDI) (DCC) 5,395.00p -1.10%
Smith (DS) (SMDS) 556.50p -1.07%
Next (NXT) 9,588.00p -0.89%
Kingfisher (KGF) 285.30p -0.73%
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.